Johnson & Johnson Big Pharma corporation loses cancer lawsuit


This video from the USA says about itself:

Johnson & Johnson Loses $55 Million Talc Powder Cancer Lawsuit

4 May 2016

Johnson & Johnson has been ordered by a jury in Missouri to pay $55 million to one woman who says that the company failed to give her and other consumers proper warning about the dangers of talc powder. Talc powder has been linked to cancer. Ana Kasparian, Brett Erlich (Pop Trigger), and Kim Horcher (Nerd Alert), hosts of The Young Turks, break it down. Tell us what you think in the comment section below.

“Johnson & Johnson (JNJ.N) was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.

The verdict, which J&J plans to appeal, was the second straight trial loss for the company, which is facing about 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products’ cancer risks.

Following a three-week trial in Missouri state court, jurors deliberated for about a day before returning a verdict for Gloria Ristesund. She was awarded $5 million in compensatory damages and $50 million in punitive damages.”*

Read more here.

See also here.

When I was young we used to have a bottle of Johnson & Johnson’s Johnson’s Baby Oil. My father used to refer to it as ‘the bottle of Johnson Murderer’. Not then because of suspicion that Johnson & Johnson products might cause cancer. Because of analogy to the name of the then president of the USA, Lyndon Baines Johnson, who was called ‘murderer’ because of his lethal Vietnam war.

JOHNSON & JOHNSON SUBPOENAED OVER BABY POWDER Johnson & Johnson said it has received subpoenas from the Justice Department and the Securities and Exchange Commission related to litigation involving alleged asbestos contamination in baby powder. [Reuters]

In Opioid Trial, Oklahoma Accuses Johnson & Johnson of Being Drug “Kingpin”: here.

The pharmaceutical company Mylan has been making headlines in recent weeks for hiking the price of its life-saving EpiPen device by more than 450 percent. A report released this past June, however, notes that the company has made similar price increases for a number of its drugs: here.